Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Reviews in Endocrine and Metabolic Disorders
Published in: Reviews in Endocrine and Metabolic Disorders 2/2010

01-06-2010

Cushing’s syndrome: Why is diagnosis so difficult?

Author: David C. Aron

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 2/2010

Login to get access

Abstract

Practicing and perfecting the art of medicine demands recognition that uncertainty permeates all clinical decisions. When delivering clinical care, clinicians face a multiplicity of potential diagnoses, limitations in diagnostic capacity, and “sub-clinical” disease identified by tests rather than by clinical manifestations. In addition, clinicians must recognize the rapid changes in scientific knowledge needed to guide decisions. Cushing’s syndrome is one of several disorders in which there may be considerable difficulty and delay in diagnosis. This article describes a current model of clinical reasoning, some of its challenges, and the application of the principles of clinical epidemiology to meet some of those challenges.
Literature
1.
De P, Evans L, Scanlon M, Davies J. “Osler’s phenomenon”: misdiagnosing Cushing’s syndrome. Postgrad Med J. 2003;79:594–6.CrossRefPubMed
2.
Fleseriu M, Ludlam W, Teh S, Yedinak C, et al. Cushing’s syndrome might be underappreciated in patients seeking bariatric surgery: a plea for screening. Surg Obes Relat Dis. 2009;5:116–22.CrossRefPubMed
3.
Boscaro M, Arnaldi G. Approach to the patient with possible Cushing’s syndrome. J Clin Endocrinol Metab. 2009;94:3121–31.CrossRefPubMed
4.
Findling JW, Raff H. Cushing’s syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab. 2006;91:3746–53.CrossRefPubMed
5.
Kater C, Vilar L, Newell P. Harvey Cushing and Philip Hench: pituitary basophilism meets cortisone excess. Arq Bras Endocrinol Metabol. 2007;51:1182–4.PubMed
6.
Muller M, Mazzuco T, Martinie M, Bachelot I, Chabre O. Diagnosis of Cushing’s syndrome: a retrospective evaluation of clinical practice. Eur J Intern Med. 2006;17:334–8.CrossRefPubMed
7.
Nieman L, Biller B, Findling J, Newell-Price J, et al. The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:1526–40.CrossRefPubMed
8.
Nugent C, Warner H, Dunn J, Tyler F. Probability theory in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab. 1964;24:621–7.CrossRefPubMed
9.
Reimondo G, Pia A, Bovio S, Allasino B, Daffara F, et al. Laboratory differentiation of Cushing’s syndrome. Clin Chim Acta. 2008;388:5–14.CrossRefPubMed
10.
Rudolph J, Morrison J. Approach to the patient with possible Cushing’s syndrome. Am J Med. 2008;121:S34–7.CrossRefPubMed
11.
Suda T, Kageyama K, Nigawara T, Sakihara S. Approach to the patient with possible Cushing’s syndrome. Endocr J. 2009;56:469–76.CrossRefPubMed
12.
Senate Resolution 498-Designating April 8, 2008, as “National Cushing’s syndrome awareness day”. S. Res. 498. 4-2-2008. Ref Type: Hearing
13.
Kassirer JP, Kopelman RI. Learning clinical reasoning. Baltimore: Lippincott, Williams & Wilkens; 1991.
14.
Sackett D, Haynes R, Guyatt G, et al. Clinical epidemiology: a basic science for clinical medicine. Boston: Little Brown and Company; 1991.
15.
HJr S, Blatt M, Higgins M, et al. Medical decision making. Boston: Butterworth-Heinmann; 1988.
16.
Croskerry P. The theory and practice of clinical decision making. Can J Anesth. 2002;52:R1–8.CrossRef
17.
18.
Croskerry P. Context is everything, or: how could I have been that stupid? Healthc Q. 2009;12:167–73.
19.
Norman G. Dual processing and diagnostic errors. Adv Health Sci Educ. 2009;14:37–49.CrossRef
20.
Evans J. Dual-processing accounts of reasoning, judgment, and social cognition. Annu Rev Psychol. 2008;59:255–78.CrossRefPubMed
21.
22.
Graber ML, Berner ES. Diagnostic error: is overconfidence the problem? Am J Med. 2008;121(5A):S1–S29. Ref Type: Journal (Full).
23.
24.
Elstein A. Thinking about diagnostic thinking: a 30-year perspective. Adv Health Sci Educ. 2009;14:18.CrossRef
25.
Croskerry P. Clinical cognition and diagnostic error: applications of a dual process model of reasoning. Adv Health Sci Educ. 2009;14:27–35.CrossRef
26.
Bleakley A, Farrow R, Gould D, Marshall R. Making sense of clinical reasoning: judgement and the evidence of the senses. Med Educ. 2003;37:544–52.CrossRefPubMed
27.
Tversky A, Kahneman D. Judgement under uncertainty: heuristics and bias. Science 1974;185:1124–31.CrossRefPubMed
28.
29.
Ross E, Linch D. Cushing’s syndrome-killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 1982;2:646–9.CrossRefPubMed
30.
Paulker S, Kopelman R. Interpreting hoofbeats:can Bayes help clear the haze. N Engl J Med. 1992;327:1009–13.CrossRef
31.
Cahan A, Gilon D, Manor O, Paltiel O. Clinical experience did not reduce the variance in physicians’ estimates of pretest probability in a cross-sectional survey. J Clin Epidemiol. 2005;58:1211–6.CrossRefPubMed
32.
Bryant G, Norman G. Expressions of probability: words and numbers. N Engl J Med. 1980;302:411.PubMed
33.
Cawood T, Hunt P, O’Shea D, Cole D, Soule S. Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur J Endocrinol. 2009;161:513–27.CrossRefPubMed
34.
Newsome S, Chen K, Hoang J, Wilson J, Potter J, Hickman P. Cushing’s syndrome in a clinic population with diabetes. Intern Med J. 2008;38:178–82.CrossRefPubMed
35.
Savastano S, Pivonelle R, Colao A. Bariatric surgery for obesity and hidden Cushing syndrome. Surg Obes Relat Dis. 2009;5:121–2.CrossRefPubMed
36.
Stiles L. Cushing syndrome and bariatric surgery: why, when, and how to evaluate preoperatively. Surg Obes Relat Dis. 2009;5:119–21.CrossRefPubMed
37.
Baid S, Rubino D, Sinaii N, Ramsey S, Frank A, Nieman L. Specificity of screening tests for Cushing’s syndrome in an overweight and obese population. J Clin Endicrinol Metab. 2009;94:3857–64.CrossRef
38.
Erwin P. Do medical students and physicians understand probability? Q J Med. 2004;97:53–6.
39.
Lyman C, Balducci L. Overestimation of test effects in clinical judgement. J Cancer Educ. 1993;8:297–307.CrossRefPubMed
40.
Lymna G, Balducci L. The effect of changing disease risk on clinical reasoning. J Gen Intern Med. 1994;9:488–95.CrossRef
41.
Richardson W. Five uneasy pieces about pre-test probability. JGIM 2002;892.
42.
Findling J, Raff H. Cushing’s disease: diagnostic evaluation. In: Swearingen B, Biller B, editors. Contemporary endocrinology: diagnosis and management of pituitary disorders. Totowa: Humana; 2008. p. 187–202.CrossRef
43.
Gabrilove J. The continuum of adrenocortical disease: a thesis and its lesson to medicine. Lancet 1965;32:634–6.
44.
Kidambi S, Raff H, Findling J. Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome. Eur J Endocrinol. 2007;157:725–31.CrossRefPubMed
45.
Aron D. Diagnostic implications of adrenal physiology and clinical epidemiology for evaluation of glucocorticoid excess and deficiency. In: DeGroot L, Jameson J, editors. Endocrinology. 4th ed. Philadelphia: Saunders; 2000.
46.
Coste J, Strauch G, Letrait M, Bertagna X. Reliability of hormonal levels for assessing the hypothalamic-pituitary-adrenocortical system in clinical pharmacology. Br J Clin Pharmacol. 1994;38:474–9.PubMed
47.
Orth DN. The Cushing syndrome: quest for the holy grail. Ann InternMed. 1994;121:377–8.
48.
49.
Oki Y, Hashimoto K, Hirata Y, Iwasaki Y, et al. Development and validation of a 0.5 mg dexamethasone suppression test as an initial screening test for the diagnosis of ACTH-dependent Cushing’s syndrome. Endocr J. 2009;56:897–904.CrossRefPubMed
50.
Halkin A, Reichman J, Schwaber M, Paltiel O, Brezis M. Likelihood ratios: getting diagnostic testing into perspective. Q J Med. 1998;91:247–58.
51.
52.
Elamin M, Murad M, Mullan R, Erickson D, et al. Accuracy of diagnostic tests for Cushing’s syndrome: a systematic review and metaanalyses. J Clin Endicrinol Metab. 2008;93:1553–62.CrossRef
53.
Giraldi F. Recent challenges in the diagnosis of Cushing’s syndrome. Horm Res. 2009;71 Suppl 1:127.
54.
Findling J, Raff H, Aron D. The low-dose dexamethasone suppression test: a re-evaluation in screening for Cushing’s syndrome. J Clin Endicrinol Metab. 2004;89:1222–6.CrossRef
55.
Albiger N, Scaroni C, Mantero F. Cyclic Cushing’s syndrome: an overview. Arq Bras Endocrinol Metabol. 2007;51:1253–60.PubMed
56.
Alexandraki K, Kaltsas G, Isidor A, Akker S, et al. The prevalence and characteristic features of cyclicity and variability in Cushing’s disease. Eur J Endocrinol. 2009;160:1011–8.CrossRefPubMed
57.
Meinardi J, Wolffenbuttel B, Dullaart R. Cyclic Cushing’s syndrome: a clinical challenge. Eur J Endocrinol. 2007;157:245–54.CrossRefPubMed
58.
Biller BMK, Sheppard M. The network for the enhancement of endocrinology and oncology knowledge: a case-based consideration of current practice in Cushing’s disease and acromegaly. Best Pract Res Clin Endocrinol Metabol. 2009;23 Suppl 1:S1–4.CrossRef
Metadata
Title
Cushing’s syndrome: Why is diagnosis so difficult?
Author
David C. Aron
Publication date
01-06-2010
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 2/2010
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-010-9127-3

Other articles of this Issue 2/2010

Reviews in Endocrine and Metabolic Disorders 2/2010 Go to the issue

OriginalPaper

Peri-operative management of Cushing’s disease

OriginalPaper

Psychosomatic aspects of Cushing’s syndrome

OriginalPaper

Is metabolic syndrome a mild form of Cushing’s syndrome?

OriginalPaper

The diagnosis of Cushing’s syndrome

OriginalPaper

The ectopic ACTH syndrome

OriginalPaper

Adrenal incidentalomas and subclinical Cushing’s syndrome
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits